<DOC>
	<DOCNO>NCT02075242</DOCNO>
	<brief_summary>Study Compare Safety Efficacy Tacrolimus Steroids Combination With Mycophenolate Mofetil Without Mycophenolate Mofetil Liver Transplantation Hepatitis B Virus ( HBsAg ) Positive</brief_summary>
	<brief_title>TO Compare Triple Drug Therapy Dual Therapy .</brief_title>
	<detailed_description />
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Tacrolimus</mesh_term>
	<mesh_term>Mycophenolate mofetil</mesh_term>
	<mesh_term>Mycophenolic Acid</mesh_term>
	<criteria>Men woman age 20 65 Patients primary Liver Transplantation becaused Chronic Hepatitis B HbsAg positive Having confirm result HBsAg positive patient within 6 month prior Screening point . Patients Liver Transplantation ABOcompatible proper live donor ⑤ Patients receive investigational product entire period clinical trial . Patients sign informed consent understand clinical trial 's purpose risk . For woman childbearing potential , pregnancy test negative urine blood AND woman agree contraception entire period clinical trial . Recipients Liver Transplantation OR organ transplantation Recipients organ transplantation addition liver . Recipients Auxiliary Partial Orthotopic Liver Transplantation . Recipients use Bioartificial liver prior Transplantation Cr &gt; 2.0mg/dl screen test Patients malignant tumor within past 5 year OR malignant tumor ( except , successfully treat Skin 's nonmetastatic basal cell carcinoma , squamous cell carcinoma primary hepatocellular carcinoma ) Recipients hepatocellular carcinoma whick Milan criterion WBC &lt; 1,500/mm3 ANC &lt; 900/mm3 PLT &lt; 30,000/mm3 Screening Investigator judge patient proper enroll study due Severe digestive disorder Screening Patients severe systemic infection ( But liver transplantation except performed infection completely lose wellcontrolled ) ⑪ Recipients Liver transplantation HBsAg positive donor ⑫ Recipients Donors HIV , HCV Positive ⑬ Patients need systemc chemotherapy immunosuppressive therapy prior transplantation take immunosuppressant within 30 day prior liver transplantation ( except , investigational product per protocol corticosteroid ) ⑭ Patients hypersensitivity mycophenolate , mycophenolate acid , ingredient investigational product , tacrolimus , Macrolide antibiotic Steroids ⑮ Patients receive received investigational product within 28 day prior screen 16 Pregnant woman lactate woman 17 Substance abuse patient , mentally defective person patient possible participate clinical trial law 18 Investigator judge patient communication disorder 19 Patients capable visit accor.ding study visit schedule 20 Investigator judge patient proper enroll study , et cetera</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>February 2014</verification_date>
	<keyword>HBV</keyword>
</DOC>